Availability and prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018-2022
View ORCID ProfileRachael K. Ross, Kara E. Rudolph, Chelsea Shover
doi: https://doi.org/10.1101/2024.01.05.24300895
Rachael K. Ross
1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY
Kara E. Rudolph
1Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY
Chelsea Shover
2Division of General Internal Medicine and Health Services Research, School of Medicine, University of California Los Angeles, Los Angeles, CA

Article usage
Posted January 07, 2024.
Availability and prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018-2022
Rachael K. Ross, Kara E. Rudolph, Chelsea Shover
medRxiv 2024.01.05.24300895; doi: https://doi.org/10.1101/2024.01.05.24300895
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)